Legend Biotech Co. (NASDAQ:LEGN) Receives $79.00 Consensus Target Price from Brokerages
Legend Biotech Co. (NASDAQ:LEGN – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the twelve ratings firms that are presently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a hold rating and eleven have issued a buy rating on the company. The average 12-month […]
Legend Biotech Co. (NASDAQ:LEGN – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the twelve ratings firms that are presently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a hold rating and eleven have issued a buy rating on the company. The average 12-month […]
